Herzschrittmachertherapie und Elektrophysiologie This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Neuigkeiten aus der Young EP
(Source: Herzschrittmachertherapie und Elektrophysiologie)
Source: Herzschrittmachertherapie und Elektrophysiologie - December 1, 2023 Category: Cardiology Source Type: research

Mitteilungen aus der Arbeitsgruppe Elektrophysiologie und Rhythmologie (AGEP)
(Source: Herzschrittmachertherapie und Elektrophysiologie)
Source: Herzschrittmachertherapie und Elektrophysiologie - December 1, 2023 Category: Cardiology Source Type: research

Neuigkeiten aus der Young EP
(Source: Herzschrittmachertherapie und Elektrophysiologie)
Source: Herzschrittmachertherapie und Elektrophysiologie - November 28, 2023 Category: Cardiology Source Type: research

Mitteilungen aus der Arbeitsgruppe Elektrophysiologie und Rhythmologie (AGEP)
(Source: Herzschrittmachertherapie und Elektrophysiologie)
Source: Herzschrittmachertherapie und Elektrophysiologie - November 28, 2023 Category: Cardiology Source Type: research

The new European Society of Cardiology guideline for the management of cardiomyopathies: key messages for cardiac electrophysiologists
AbstractElectrocardiographic findings and arrhythmias are common in cardiomyopathies. Both may be an early indication of a  specific diagnosis or may occur due to myocardial fibrosis and/or reduced contractility. Brady- and tachyarrhythmias significantly contribute to increased morbidity and mortality in patients with cardiomyopathies. Antiarrhythmic therapy including risk stratification is often challenging and plays a major role for these patients. Thus, an “electrophysiological” perspective on guidelines on cardiomyopathies may be warranted. As the European Society of Cardiology (ESC) has recently published a new...
Source: Herzschrittmachertherapie und Elektrophysiologie - November 16, 2023 Category: Cardiology Source Type: research

Langzeitergebnisse der interventionellen Rhythmustherapie
(Source: Herzschrittmachertherapie und Elektrophysiologie)
Source: Herzschrittmachertherapie und Elektrophysiologie - November 16, 2023 Category: Cardiology Source Type: research

The new European Society of Cardiology guideline for the management of cardiomyopathies: key messages for cardiac electrophysiologists
AbstractElectrocardiographic findings and arrhythmias are common in cardiomyopathies. Both may be an early indication of a  specific diagnosis or may occur due to myocardial fibrosis and/or reduced contractility. Brady- and tachyarrhythmias significantly contribute to increased morbidity and mortality in patients with cardiomyopathies. Antiarrhythmic therapy including risk stratification is often challenging and plays a major role for these patients. Thus, an “electrophysiological” perspective on guidelines on cardiomyopathies may be warranted. As the European Society of Cardiology (ESC) has recently published a new...
Source: Herzschrittmachertherapie und Elektrophysiologie - November 16, 2023 Category: Cardiology Source Type: research

Langzeitergebnisse der interventionellen Rhythmustherapie
(Source: Herzschrittmachertherapie und Elektrophysiologie)
Source: Herzschrittmachertherapie und Elektrophysiologie - November 16, 2023 Category: Cardiology Source Type: research

Incomplete (partial) left anterior hemiblock
This report describes two electrocardiograms (ECGs) showing unusual manifestations of left anterior hemiblock (LAH). One revealed different degrees of incomplete LAH and the other documented the occurrence of 2:1 LAH. Understanding different degrees of LAH helps to interpret the ECG with regard to intraventricular conduction disorders and other ECG abnormalities. (Source: Herzschrittmachertherapie und Elektrophysiologie)
Source: Herzschrittmachertherapie und Elektrophysiologie - November 14, 2023 Category: Cardiology Source Type: research

Zero-fluoro atrioventricular-nodal reentrant tachycardia ablation
ConclusionZero-fluoro RFCA in patients with AVNRT is feasible and safe. 3D-EAM can reduce radiation exposure in the majority of patients without prolonging procedure duration or increasing complications. (Source: Herzschrittmachertherapie und Elektrophysiologie)
Source: Herzschrittmachertherapie und Elektrophysiologie - November 10, 2023 Category: Cardiology Source Type: research

Die Genetik von Vorhofflimmern  – auf dem Weg in die Präzisionsmedizin
ZusammenfassungVorhofflimmern (VHF) ist eine verbreitete Herzkrankheit mit komplexer genetischer Grundlage. Trotz der Fortschritte in der Behandlung bleibt die Sterblichkeit bei VHF-Patienten hoch. Diese Übersichtsarbeit diskutiert die genetische Basis von VHF und ihre Auswirkungen auf Diagnose und Therapie. Während seit Langem eine hereditäre Komponente bei VHF bekannt war, wurden die ersten mit VHF assoziierten Gene in den frühen 2000er Jahren identifiziert. Mit Hilfe von genomweiten Assoziati onsstudien (GWAS) wurden weitere Gene und zahlreiche genetische Varianten, die mit VHF in Verbindung stehen, identifiziert. D...
Source: Herzschrittmachertherapie und Elektrophysiologie - November 6, 2023 Category: Cardiology Source Type: research

Transient loss of atrial capture: the “atrial pacemaker stunning” phenomenon
AbstractAtrial loss of capture in the chronic phase after implantation may be permanent due to various causes, e.g. technical lead problems or increased scar tissue formation around the lead tip. However, it may also be transient after atrial ischemia in the context of occlusion of the right coronary artery. In this case, it may be preferable to wait for recovery, which may take up to 45  days, instead of immediately performing an atrial lead revision. (Source: Herzschrittmachertherapie und Elektrophysiologie)
Source: Herzschrittmachertherapie und Elektrophysiologie - November 6, 2023 Category: Cardiology Source Type: research